|
MTMR9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.53819999971061E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.69909999997642E-06 |
| Normal-vs-Stage2 |
4.304800E-03 |
| Normal-vs-Stage3 |
4.982400E-03 |
| Normal-vs-Stage4 |
3.915900E-02 |
| Stage1-vs-Stage2 |
9.410400E-01 |
| Stage1-vs-Stage3 |
8.740000E-01 |
| Stage1-vs-Stage4 |
5.454600E-01 |
| Stage2-vs-Stage3 |
8.459400E-01 |
| Stage2-vs-Stage4 |
6.134000E-01 |
| Stage3-vs-Stage4 |
5.161000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60770000001698E-06 |
| Normal-vs-AfricanAmerican |
4.41290000000594E-05 |
| Normal-vs-Asian |
3.74560000004909E-06 |
| Caucasian-vs-AfricanAmerican |
8.409600E-01 |
| Caucasian-vs-Asian |
1.280180E-01 |
| AfricanAmerican-vs-Asian |
1.027430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.52840000339816E-08 |
| Normal-vs-Female |
1.048270E-02 |
| Male-vs-Female |
6.828300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.566680E-04 |
| Normal-vs-Extreme_Weight |
1.47780000003817E-06 |
| Normal-vs-Obese |
1.790700E-04 |
| Normal-vs-Extreme_Obese |
4.141700E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.338600E-01 |
| Normal_Weight-vs-Obese |
5.271000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.896000E-01 |
| Extreme_Weight-vs-Obese |
4.083000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.480600E-01 |
| Obese-vs-Extreme_Obese |
8.099600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.867600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.432200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.73620000493347E-08 |
| Normal-vs-Age(81-100Yrs) |
1.56054000000072E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.252200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.049800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.330250E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.745700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.576300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.706800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.08129999998319E-06 |
| Normal-VS-Type2 PRCC |
1.2607999999581E-06 |
| Normal-VS-KIRP CIMP |
7.237600E-01 |
| Normal-VS-Unclassified PRCC |
6.212300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.149800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.002960E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.368000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.230400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.664980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.712400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.62330000236844E-08 |
| Normal-vs-N1 |
7.898000E-03 |
| Normal-vs-N2 |
5.177400E-01 |
| N0-vs-N1 |
2.654400E-01 |
| N0-vs-N2 |
6.437000E-01 |
| N1-vs-N2 |
8.221200E-01 |
|
|
